Trial NCT00493766

View at ClinicalTrials.gov 
Org. Study IDs: CLBH589B2105

Last trial update was posted on 2020-12-19

MeSH Interventions

Panobinostat

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Hormone Refractory Prostate Cancer

Stopping Reasons

Because of a strategic decision by Novartis

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID